Therapeutic options in recurrent glioblastoma--An update

Critical Reviews in Oncology/hematology
Katharina SeystahlMichael Weller

Abstract

Standards of care are not yet defined in recurrent glioblastoma. We reviewed the literature on clinical trials for recurrent glioblastoma available in PubMed and American Society of Clinical Oncology (ASCO) abstracts until June 2015. Evidence is limited due to the paucity of randomized controlled studies. Second surgery or re-irradiation are options for selected patients. Alkylating chemotherapy such as nitrosoureas or temozolomide and the vascular endothelial growth factor (VEGF) antibody, bevacizumab, exhibit comparable single agent activity. Phase III data exploring the benefit of combining bevacizumab and lomustine are emerging. Novel approaches in the fields of targeted therapy, immunotherapy, and tumor metabolism are coming forward. Several biomarkers are being explored, but, except for O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation, none has assumed a role in clinical practice. Proper patient selection, development of predictive biomarkers and randomized controlled studies are required to develop evidence-based concepts for recurrent glioblastoma.

References

Jun 16, 2000·Oncology Reports·J GuyotatP Bret
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Feb 11, 2004·Neuro-oncology·Michael D PradosUNKNOWN North American Brain Tumor Consortium study
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesUNKNOWN Gruppo Italiano Cooperativo di Neuro-Oncologia
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James J VredenburghHenry S Friedman
Apr 13, 2007·The New England Journal of Medicine·Florence Keime-GuibertUNKNOWN Association of French-Speaking Neuro-Oncologists
Jul 13, 2007·The New England Journal of Medicine·Stephen Hanna
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antje WickWolfgang Wick
Sep 1, 2007·BMC Cancer·Stephanie E CombsDaniela Schulz-Ertner
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Mar 22, 2008·Neuro-oncology·Kathleen R LambornUNKNOWN North American Brain Tumor Consortium
Jun 24, 2008·British Journal of Neurosurgery·Giuseppe M V BarbagalloAndrew R Brodbelt
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A ReardonL Burt Nabors
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teri N KreislHoward A Fine
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A QuinnHenry S Friedman
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentThierry Gorlia
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisJan C Buckner
Aug 12, 2009·Journal of Neuro-oncology·A BerrocalUNKNOWN GENOM Cooperative Group
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Jan 13, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J J C VerhoeffD J Richel
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickHoward A Fine
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R PerryJean-François Pouliot
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy T BatchelorRakesh K Jain
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shannon E FoghMaria Werner-Wasik
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ParkPeter McL Black
Aug 10, 2010·Journal of Neuro-oncology·Raffaele AddeoSalvatore Del Prete
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael BradaSiow-Ming Lee
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John F de GrootPatrick Y Wen

❮ Previous
Next ❯

Citations

Apr 8, 2016·Expert Opinion on Pharmacotherapy·Katharina SeystahlMichael Weller
Oct 8, 2016·Neuroimaging Clinics of North America·Mark F Dalesandro, Jalal B Andre
Apr 12, 2017·Hormones & Cancer·Thangirala SudhaShaker A Mousa
Apr 4, 2017·Current Opinion in Neurology·David A ReardonJohn H Sampson
Apr 26, 2017·Expert Review of Anticancer Therapy·Thomas HundsbergerPatrick Y Wen
Nov 20, 2016·Neurosurgery·Analiz Rodriguez, Stephen B Tatter
Apr 24, 2017·World Neurosurgery·Christoph SchwartzPeter A Winkler
Apr 13, 2017·Praxis·Thomas Hundsberger, Michael Weller
Aug 22, 2018·Expert Opinion on Investigational Drugs·Yu-Long LanBo Zhang
Aug 14, 2018·Current Opinion in Oncology·Mirco FriedrichMichael Platten
Oct 23, 2018·Technology in Cancer Research & Treatment·Thomas ReynaudNoémie Vulquin
Mar 7, 2018·The Journal of Pharmacology and Experimental Therapeutics·Emese SzabóMichael Weller
Jul 31, 2019·International Journal of Molecular Sciences·Niklas ZimmerAndrea Tuettenberg
Aug 2, 2018·EMBO Molecular Medicine·Nevenka Dudvarski StankovićMirko H Schmidt
Aug 20, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Srishti AgarwalD Sakthi Kumar
Oct 12, 2017·Journal of Oncology Practice·Joo Yeon Nam, John F de Groot
Jan 22, 2020·Journal of Cellular Biochemistry·Yuhualei PanYan-Bing Zhu
May 24, 2020·Medicinal Research Reviews·Ge YanZhiqiang Li
May 12, 2018·Molecular Medicine Reports·Dongwei DaiBo Hong
Aug 14, 2020·Journal of Neuropathology and Experimental Neurology·Stine Asferg PettersonBjarne Winther Kristensen
Nov 9, 2019·BMJ : British Medical Journal·Shing Fung LeeFrank Chi Sing Wong
Sep 12, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Georgios ChatzikonstantinouNikolaos Tselis
Jan 18, 2019·JCO Clinical Cancer Informatics·Cédric M PanjePaul M Putora
Dec 5, 2017·Future Oncology·Philip A SuteraDwight E Heron
Feb 8, 2019·Cancer Investigation·Maria Dinche JohansenHans Skovgaard Poulsen
Mar 31, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P D Delgado-LópezS Tejada
May 20, 2018·Journal of Neuro-oncology·Roelant S EijgelaarMarnix G Witte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Cancer Treatment and Research
Vyshak Alva VenurManmeet S Ahluwalia
Clinical Advances in Hematology & Oncology : H&O
Solmaz SahebjamWarren P Mason
© 2021 Meta ULC. All rights reserved